SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02096 SIMCERE PHARMA

Not Yet Opened 03-09 16:08:19

11.650

-0.170

-1.44%

High11.730	Low11.360	Vol4.43M
Open11.730	D1 Closing11.820	Amplitude3.13%
Mkt Cap30.24B	Tradable Cap30.24B	Total Shares2.60B
T/O51.18M	T/O Rate0.17%	Tradable Shares2.60B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"SIMCERE PHARMA","latestPrice":11.65,"timestamp":1773043699002,"preClose":11.82,"halted":0,"volume":4426000,"delay":0,"changeRate":-0.014382402707275798,"floatShares":2596000000,"shares":2596000000,"eps":0.3291390448779114,"marketStatus":"Not Yet Opened","change":-0.17,"latestTime":"03-09 16:08:19","open":11.73,"high":11.73,"low":11.36,"amount":51183759,"amplitude":0.031303,"askPrice":11.66,"askSize":2000,"bidPrice":11.65,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":0.42220594722270016,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":0,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":11.82,"dividendRate":0.015004,"openAndCloseTimeList":[[1773019800000,1773028800000],[1773032400000,1773043200000]],"volumeRatio":0.6726547018355319,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096","defaultTab":"news","newsList":[{"id":"1125071764","title":"Simcere Pharma (02096.HK) Releases Monthly Return for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1125071764","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125071764?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:05","pubTimestamp":1772615150,"startTime":"0","endTime":"0","summary":"According to the announcement, Simcere Pharma reported a total of 2.60 billion issued shares as of February 28, 2026, unchanged from the preceding month. The public float requirement of 15.45%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"1160277872","title":"SIMCERE PHARMA Anticipates Significant Profit Surge for Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1160277872","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160277872?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:28","pubTimestamp":1772011714,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) has announced preliminary projections for the fiscal year ending December 31, 2025. Based on an initial review of the company's unaudited consolidated management accounts, the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"1169652560","title":"Simcere Pharmaceutical Group Limited (2096) Issues FY2025 Profit Alert","url":"https://stock-news.laohu8.com/highlight/detail?id=1169652560","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169652560?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:25","pubTimestamp":1772011538,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (2096) announced a profit alert for the fiscal year ended December 31, 2025 (FY2025). According to a preliminary assessment of the unaudited consolidated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"2614704032","title":"Simcere Pharmaceutical - Expects Profit of RMB1,300 Mln to RMB1,400 Mln in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2614704032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614704032?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:17","pubTimestamp":1772011042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0Q5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2614040377","title":"Simcere Pharmaceutical - Expects FY2025 Revenue of Around RMB7,700 Mln to RMB7,800 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614040377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614040377?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:17","pubTimestamp":1772011042,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0Q5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2614047027","title":"Simcere Pharmaceutical Expects FY2025 Profit Attributable to Shareholders of RMB1.3 Billion to RMB1.4 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2614047027","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614047027?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:16","pubTimestamp":1772011017,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Ltd. expects FY2025 revenue of about RMB7.7 billion to RMB7.8 billion, up roughly 16.0% to 17.6% from the restated RMB6.635 billion in FY2024. Profit attributable to equity shareholders is forecast at around RMB1.3 billion to RMB1.4 billion, an increase of about 80.1% to 93.9% versus the restated RMB722 million a year earlier, while adjusted profit attributable to equity shareholders is expected to be RMB1.25 billion to RMB1.35 billion, up about 24.1% to 34.1% from the restated RMB1.007 billion. The company attributed the improvement mainly to higher revenue from its innovative pharmaceutical business, out-licensing income, and fair value gains on its investment portfolio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL3NdFXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"1137709320","title":"SIMCERE PHARMA Rises Over 3% in Morning Trading as Guojin Securities Reiterates \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1137709320","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137709320?lang=en_us&edition=fundamental","pubTime":"2026-02-13 10:51","pubTimestamp":1770951094,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) saw its shares climb more than 3% during the trading session. At the time of writing, the stock was up 2.93%, trading at HKD 12.64, with a turnover of HKD 237.223 million....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"1162602450","title":"SIMCERE PHARMA Shares Rise Over 3% Following $40 Million Milestone Payment for Core Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1162602450","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162602450?lang=en_us&edition=fundamental","pubTime":"2026-02-13 10:46","pubTimestamp":1770950770,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) saw its shares increase by more than 3%. At the time of writing, the stock was up 2.69%, trading at HK$12.61, with a turnover of HK$22.02 million. The movement follows a recent...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","VXUS","BK1583","VT","BK1191","BK4588","BK4585"],"gpt_icon":0},{"id":"2609830671","title":"Simcere Pharmaceutical Group’s Valuation After SIM0709 Licensing Deal With Boehringer Ingelheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2609830671","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609830671?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:26","pubTimestamp":1770297986,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group (SEHK:2096) has drawn investor attention after announcing an exclusive licensing agreement with Boehringer Ingelheim for SIM0709, a TL1A/IL-23p19 bispecific antibody targeting inflammatory bowel disease.\nSee our latest analysis for Simcere Pharmaceutical Group.\nThe licensing news arrives after a mixed year in the market, with Simcere’s 1-year total shareholder return of 77.9% contrasting with a year to date share price return of 0.85% and a 90 day share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-groups-valuation-after-sim0709-licens","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-groups-valuation-after-sim0709-licens","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02096","BK1191","BK1583","DCF"],"gpt_icon":0},{"id":"1138323149","title":"Guojin Securities Reiterates \"Buy\" on Simcere Pharma Following SIM0500 Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1138323149","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138323149?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:08","pubTimestamp":1770278907,"startTime":"0","endTime":"0","summary":"Guojin Securities has released a research report maintaining a \"Buy\" rating on Simcere Pharma (02096). The report notes the company's continued strengthening of its innovative transformation, with...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1191","BK1583"],"gpt_icon":0},{"id":"1137190585","title":"Simcere (02096) Releases January 2026 Monthly Return With No Change in Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1137190585","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137190585?lang=en_us&edition=fundamental","pubTime":"2026-02-04 16:55","pubTimestamp":1770195316,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (02096) published its monthly return for the period ended January 31, 2026, confirming that the total number of issued shares remained at 2,595,697,618 with no...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"1173966287","title":"Simcere Pharmaceutical Group Limited (Stock Code: 2096) Announces Receipt of US$40 Million Milestone Payment Under SIM0500 Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1173966287","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173966287?lang=en_us&edition=fundamental","pubTime":"2026-02-03 17:06","pubTimestamp":1770109568,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (the “Group”), which entered into an option to license agreement with a subsidiary of AbbVie Inc. (“AbbVie”) for an investigational new drug candidate known as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"1145120976","title":"SIMCERE PHARMA (02096) Receives Recent Milestone Payment from AbbVie for SIM0500 Overseas License Option Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1145120976","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145120976?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:45","pubTimestamp":1770108320,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that its group subsidiary has entered into an overseas license option agreement with an affiliate of AbbVie Inc. for the investigational new drug candidate SIM0500....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2608825950","title":"Simcere Pharmaceutical Group erhält Meilensteinzahlung von AbbVie für SIM0500","url":"https://stock-news.laohu8.com/highlight/detail?id=2608825950","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608825950?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:39","pubTimestamp":1770107953,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL147c9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","IE00BDGV0183.EUR","IE00BJT1NW94.SGD","LU0114720955.EUR","LU1291159041.SGD","BK1191","IE00BGHQF631.EUR","LU2023251221.USD","LU2089984988.USD","02096","IE0009355771.USD","LU0708994859.HKD","LU0912757837.SGD","LU0310799852.SGD","LU1244550221.USD","LU1732800096.USD","LU0158827948.USD","SG9999015952.SGD","LU0820561818.USD","LU0203345920.USD","LU0553294199.USD","LU2087621335.USD","IE00BVYPNV92.GBP","LU2133065610.SGD","LU1496350171.SGD","LU0795875169.SGD","BK4533","LU1585245621.USD","LU1929549753.HKD","ABBV","IE00B42XCP33.USD","LU0128525929.USD","LU1718418525.SGD","LU0949170772.SGD","IE00BLSP4452.SGD","LU0861579265.USD","LU0069063385.USD","LU0511384066.AUD","IE00BN8TJ469.HKD","LU0256863811.USD","BK4585","LU1983299246.USD","LU0057025933.USD","LU0234570918.USD","LU1989772840.SGD","LU1023059063.AUD","IE0002141913.USD","LU1244550577.SGD","IE00B3PB1722.GBP","BK4534"],"gpt_icon":0},{"id":"1188266695","title":"Simcere Pharmaceutical Group (2096) Announces Exclusive Licensing Agreement with Boehringer Ingelheim","url":"https://stock-news.laohu8.com/highlight/detail?id=1188266695","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188266695?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:44","pubTimestamp":1769503494,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (Stock code: 2096) has announced that on January 26, 2026, its subsidiary, Jiangsu Simcere Pharmaceutical Co., Ltd., entered into an exclusive licensing agreement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"2606201675","title":"BRIEF-Simcere Pharmaceutical Enters Exclusive Licensing Agreement With Boehringer Ingelheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2606201675","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606201675?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:38","pubTimestamp":1769503094,"startTime":"0","endTime":"0","summary":"BRIEF-Simcere Pharmaceutical Enters Exclusive Licensing Agreement With Boehringer IngelheimJan 27 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:ENTERS EXCLUSIVE LICENSING AGREEMENT WITH BOEHRIN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YR102:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"gpt_icon":0},{"id":"1154374435","title":"SIMCERE PHARMA (02096) Signs Exclusive Licensing Agreement with Boehringer Ingelheim for SIM0709 (TL1A/IL-23p19 Bispecific Antibody)","url":"https://stock-news.laohu8.com/highlight/detail?id=1154374435","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154374435?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:36","pubTimestamp":1769502985,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that on January 26, 2026, its subsidiary, Simcere Pharmaceutical Co., Ltd. (Jiangsu Simcere), entered into an exclusive licensing agreement with Boehringer Ingelheim....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2606620133","title":"Simcere Signs Exclusive Global Licensing Agreement With Boehringer Ingelheim for SIM0709","url":"https://stock-news.laohu8.com/highlight/detail?id=2606620133","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606620133?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:30","pubTimestamp":1769502635,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Ltd. announced that its subsidiary, Jiangsu Simcere Pharmaceutical Co., Ltd., has entered into an exclusive licensing agreement with Boehringer Ingelheim. Under the agreement, Boehringer Ingelheim will have the exclusive global rights, outside of Greater China, to SIM0709, a TL1A/IL-23p19 bispecific antibody developed for the treatment of inflammatory bowel disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL847plx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2606802201","title":"Simcere Pharmaceutical - Eligible for EUR42 Mln Upfront and up to EUR1,016 Mln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2606802201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606802201?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:30","pubTimestamp":1769502634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YR102:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2606020187","title":"Simcere Pharmaceutical - Boehringer Ingelheim Granted Exclusive Rights to Sim0709 Outside Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2606020187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606020187?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:30","pubTimestamp":1769502634,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YR102:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1583","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.1558},{"period":"6month","weight":-0.1588},{"period":"1year","weight":0.4841},{"period":"ytd","weight":-0.0267}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093182},{"month":2,"riseRate":0.666667,"avgChangeRate":0.070781},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.028184},{"month":4,"riseRate":0.6,"avgChangeRate":0.009116},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"SIMCERE PHARMA","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIMCERE PHARMA,02096,SIMCERE PHARMA股票,SIMCERE PHARMA股票老虎,SIMCERE PHARMA股票老虎国际,SIMCERE PHARMA行情,SIMCERE PHARMA股票行情,SIMCERE PHARMA股价,SIMCERE PHARMA股市,SIMCERE PHARMA股票价格,SIMCERE PHARMA股票交易,SIMCERE PHARMA股票购买,SIMCERE PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}